Last Price$25.73NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/27/20

Today's Change+1.18(4.81%)
Bid (Size)$24.80 (3)
Ask (Size)$25.00 (4)
Day Low / High$24.40 - 26.07
Volume914.8 K

View Biotechnology IndustryPeer Comparison as of 01/27/2020


Alector Inc ( NASDAQ )

Price: $25.73
Change: +1.18 (4.81%)
Volume: 914.8 K
4:00PM ET 1/27/2020

Regenxbio Inc ( NASDAQ )

Price: $43.36
Change: -0.62 (1.41%)
Volume: 292.6 K
4:00PM ET 1/27/2020

Insmed Inc ( NASDAQ )

Price: $19.74
Change: -0.35 (1.74%)
Volume: 774.8 K
4:00PM ET 1/27/2020

Fate Therapeutics Inc ( NASDAQ )

Price: $24.33
Change: +0.17 (0.70%)
Volume: 606.5 K
4:00PM ET 1/27/2020

Ligand Pharmaceuticals Inc ( NASDAQ )

Price: $86.54
Change: -2.00 (2.26%)
Volume: 415.0 K
4:00PM ET 1/27/2020

Read more news Recent News

MT Newswires After-Hours News Movers
5:53PM ET 1/27/2020 MT Newswires

Some of the stocks moving on news-driven events in Monday's after-hours include: XLRN, +68.34% SURF, +13.79% DESP, +8.76% GGG, +4.57% CNCE, +2.22% BRO,...

Alector Plans to Sell About 5.1 Million Shares - Stock Down Almost 5% After-Hours
5:18PM ET 1/27/2020 MT Newswires

Alector (ALEC), a clinical-stage biotechnology company, said on Monday it plans to sell about 5.1 million shares in an underwritten public offering through...

Alector Starts Dosing in Trial of Treatment for Alzheimer's, Parkinson's
12:00PM ET 1/06/2020 MT Newswires

Biotechnology company Alector Inc. (ALEC) said Monday that it has initiated the dosing of patients in its Phase 1 study of AL101 last month. The trial is...

Alector Hires Former Theravance Senior Vice President as Chief Operating Officer
5:21PM ET 12/11/2019 MT Newswires

Alector (ALEC) late Wednesday said it has named Dr. Shehnaaz Suliman to be its new chief operating officer, with the former Theravance Biopharma (TBPH)...

View all Commentary and Analysis

Alector: A Promising Neuro-Immunology Pick For 2020
8:00PM ET 1/27/2020 Seeking Alpha

Netflix, Cisco And Chewy On The Marquee (Stocks To Watch Podcast)
7:30AM ET 12/08/2019 Seeking Alpha

Stocks To Watch: Netflix, Cisco And Chewy On The Marquee
9:03AM ET 12/07/2019 Seeking Alpha

Buy Bellus Health Before It Hits The Nasdaq
5:06PM ET 9/15/2019 Seeking Alpha

Company Profile

Business DescriptionAlector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA. View company web site for more details
Address151 Oyster Point Boulevard
South San Francisco, California 94080
Number of EmployeesN/A
Recent SEC Filing01/27/20204
Chief Executive Officer & DirectorArnon Rosenthal
President & Chief Operating OfficerShehnaaz Suliman
Chief Financial & Accounting OfficerCalvin Yu
Chief Medical OfficerRobert Paul

Company Highlights

Price Open$24.77
Previous Close$24.55
52 Week Range$13.64 - 27.00
Market Capitalization$1.8 B
Shares Outstanding68.9 M
SectorHealth Technology
Next Earnings Announcement03/24/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.51
Beta vs. S&P 500N/A
Revenue$27.7 M
Net Profit Margin-378.57%
Return on Equity-43.73%

Analyst Ratings as of 01/27/2020

Consensus RecommendationConsensus Icon
Powered by Factset